Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-04-03 Purchase |
2023-04-04 5:10 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director |
8,809 | $2.2157 | $19,518 | 26,809 (Direct) |
View |
2023-03-16 Purchase |
2023-03-16 5:10 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
26,000 | $2.039 | $53,014 | 1,179,098 (Indirect Direct) |
View |
2023-03-14 Purchase |
2023-03-15 5:25 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
100,000 | $2.01 | $201,000 | 1,153,098 (Indirect Direct) |
View |
2023-03-14 Sale |
2023-03-15 5:20 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer |
100,000 | $2.01 | $201,000 | 201,666 (Direct) |
View |
2023-03-13 Purchase |
2023-03-15 5:15 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director |
70,000 | $2.0224 | $141,570 | 86,500 (Direct) |
View |
2023-01-03 Sale |
2023-01-04 07:24 am |
ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer |
13,325 | $12.55 | $167,195 | 126,143 (Direct) |
View |
2021-11-01 Sale |
2022-05-10 5:30 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director |
3,000 | $25.6 | $76,800 | 0 (Direct) |
View |
2022-03-21 Sale |
2022-03-22 8:30 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
10,000 | $9.4096 | $94,096 | 46,661 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-17 Option Award |
2023-04-20 06:00 am |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer |
213,000 | $0 | 414,666 (Direct) |
View |
2023-04-17 Option Award |
2023-04-20 06:00 am |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
97,500 | $0 | 205,500 (Direct) |
View |
2023-04-17 Option Award |
2023-04-20 06:00 am |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director |
30,000 | $0 | 56,809 (Direct) |
View |
2022-10-27 Gift |
2022-10-28 9:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
25,000 | $0 | 1,053,098 (Direct) |
View |
2022-08-08 Exercise |
2022-08-10 4:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director |
20,000 | $4.08 | 28,696 (Direct) |
View |
2022-08-08 Tax Withholding |
2022-08-10 4:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director |
9,304 | $8.77 | 28,696 (Direct) |
View |
2022-08-08 Exercise |
2022-08-10 4:30 pm |
N/A 2022-08-08 |
ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director |
20,000 | $0 | 28,696 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:01 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director |
12,000 | $0 | 16,500 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:01 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director |
12,000 | $0 | 18,000 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer |
30,000 | $0 | 48,000 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer |
118,000 | $0 | 301,666 (Direct) |
View |
2022-08-01 Tax Withholding |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
12,631 | $8.36 | 1,078,098 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
160,000 | $0 | 1,078,098 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO |
42,000 | $0 | 166,333 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director |
12,000 | $0 | 18,000 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
39,000 | $0 | 108,000 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer |
30,000 | $0 | 139,468 (Direct) |
View |
2022-01-03 Option Award(A) |
2022-05-10 5:32 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director |
6,000 | $0 | 6,000 (Direct) |
View |
2022-05-02 Option Award |
2022-05-03 5:30 pm |
N/A 2032-05-02 |
ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director |
12,000 | $0 | 12,000 (Direct) |
View |
2022-02-17 Exercise |
2022-02-22 5:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
6,667 | $4.8 | 56,661 (Direct) |
View |
2022-02-17 Exercise |
2022-02-22 5:30 pm |
2020-12-30 2030-01-08 |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
6,667 | $0 | 56,661 (Direct) |
View |
2022-02-17 Tax Withholding |
2022-02-22 5:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
3,010 | $10.63 | 56,661 (Direct) |
View |
2022-02-11 Gift(A) |
2022-02-15 5:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
5,000 | $0 | 53,004 (Direct) |
View |
2022-02-11 Gift |
2022-02-14 5:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
5,000 | $0 | 47,004 (Direct) |
View |
2022-01-09 Option Award |
2022-01-11 8:40 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer |
48,000 | $0 | 48,000 (Direct) |
View |
2022-01-03 Tax Withholding(A) |
2022-01-11 8:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
48,752 | $13.89 | 1,037,729 (Direct) |
View |
2022-01-03 Option Award(A) |
2022-01-11 8:30 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
320,000 | $0 | 1,037,729 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:52 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director |
16,000 | $0 | 154,889 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:51 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director |
16,000 | $0 | 19,000 (Direct) |
View |
2022-01-03 Tax Withholding |
2022-01-05 8:41 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
48,752 | $13.89 | 1,057,729 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:41 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
320,000 | $0 | 1,057,729 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:39 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer |
114,000 | $0 | 255,666 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:38 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer |
51,000 | $0 | 141,468 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:35 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
16,000 | $0 | 68,004 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:33 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO |
57,000 | $0 | 160,333 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:32 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
51,000 | $0 | 101,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:30 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Friedman Aviad Director |
16,000 | $0 | 10,000 (Direct) |
View |
2022-01-03 Gift |
2022-01-05 8:30 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Friedman Aviad Director |
16,000 | $0 | 10,000 (Direct) |
View |